Basic Information
LACIPIL TABLET 4 mg
TABLET, FILM COATED
Regulatory Information
SIN07934P
November 25, 1994
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XC08CA09
Company Information
Active Ingredients
LACIDIPINE
Strength: 4 mg
Detailed Information
Contraindications
**Contraindications** - Hypersensitivity to any component of the preparation. - As with other dihydropyridines, _LACIPIL_ is contraindicated in patients with severe aortic stenosis.
Indication Information
**Indications** As a treatment of hypertension either alone or in combination with other antihypertensive agents, e.g. beta-blockers, diuretics and ACE inhibitors.